In three clinical strains of Staphylococcus aureus and one laboratory mutant (609 str-r) the gene determining streptomycin resistance was probably at a single chromosomal locus. Cell-free systems from these, and an additional clinical strain, showed little inhibition of protein synthesis in the presence of streptomycin, whereas systems from sensitive staphylococci were markedly affected by streptomycin.
In three clinical strains of Staphylococcus aureus and one laboratory mutant (609 str-r) the gene determining streptomycin resistance was probably at a single chromosomal locus. Cell-free systems from these, and an additional clinical strain, showed little inhibition of protein synthesis in the presence of streptomycin, whereas systems from sensitive staphylococci were markedly affected by streptomycin.
I N T R O D U C T I O N
Streptomycin is an inhibitor of bacterial protein synthesis and streptomycin-resistant mutants obtained in vitro have abnormal ribosomes (Spotts & Stanier, 1961 ; Weisblum & Davies, 1968) . The gene determining this type of resistance has a chromosomal location (Poston, 1966; Novick & Morse, 1967; Lacey, 1972) .
However, in clinical isolates of Escherichia coli streptomycin-resistance occurs by enzymatic inactivationeither adenylation or phosphorylation (Davies, Brzezinska & Benviste, 197r ; Smith, 1971) , the relevant genes being carried by R factors. In these strains there is no evidence of modified ribosomes.
In a few clinical strains of Staphylococcus aureus there is some evidence for a plasmid locus or gene(s) determining streptomycin resistance (Ayliffe, 1970; Grubb & O'Reilly, 197 I) . The mechanism of resistance is uncertain. We have studied the genetical and biochemical basis of streptomycin resistance in four clinical strains of Staphylococcus aureus. The nature of the resistance in these strains seems identical to that of mutants selected in vitro.
M E T H O D S
Strains of Staphylococcus aureus. Strains I 3 I 36, I 3 I 37, I I I 64 and 2273 are multi-resistant strains isolated in 1960, 1960, 1964 and 1967 respectively from clinical material. They were obtained, freeze-dried, from the Cross Infection Laboratory, Colindale, London, N. W.9. The minimum inhibitory concentration (MIC) of streptomycin was about 2000 ,ug/ml for each. Strain 609 str-r (MIC 2000 ,ug/ml) is a one-step streptomycin-resistant mutant of strain 609 (MIC 0.5 ,ug/ml) selected in vitro; the gene for streptomycin resistance in strain 609 sir-r is chromosomal (Lacey, 1972) . Strain 8325 (MIC of streptomycin 0.5 pglml) is the propagating strain (PS) of phage 47 in the International Basic Set. The recipient strain in transduction experiments was ~~5 4 .
Media, antibiotic sensitivity, mitomycin C induction, and transduction were as described previously (Lacey, I 97 I).
Curing. Attempts to cure streptomycin resistance were performed with rifampicin (Johnson & Richmond, I970), acriflavine (Dornbush, Hallander & Lofquist, 1969) and growth for 18 h at 43 "C. Material for cell-free system. Uniformly 14C-labelled L-amino acid mixture (54 mCi/ mAtom) was obtained from the Radiochemical Centre, Amersham, Buckinghamshire. Ribonuclease A five times crystallized, deoxyribonuclease I electrophoretically pure, ATP and GTP were obtained from Sigma Chemical Co., London. Lysostaphin was obtained from Schwarz-Mann Laboratories, Orangeburg, New Jersey, U.S.A., puromycin from Nutritional Biochemicals Co., Cleveland, Ohio, U.S.A., and chloramphenicol from Parke-Davis Co., Hounslow, Middlesex.
Preparation of cell-free extracts. Overnight broth cultures were diluted I in 25 into fresh warmed broth and grown at 37 "C with aeration to cell densities equivalent to 0.35 mg dry wt/ml (about 2-5 h). Cells from a litre of culture were then harvested by centrifugation at 4 "C, washed twice in 0-05 M-tris-hydrochloric acid buffer, pH 7.6, containing: ammonium acetate, 50 mM; magnesium chloride, 20 mM; potassium chloride, 50 mM; and dithiothreitol, 0.2 mM (TAMKSH buffer).
Washed cells were resuspended in 10 ml of TAMKSH buffer, lysotaphin added to 50 pg/ml and incubated for 10 min at 37 "C. Then deoxyribonuclease (5 pg/ml) was added and incubation continued for 30 s. The resultant lysates were cooled to 4 "C and centrifuged at ~o o o o g for 30 min to remove residual whole cells. The supernatants were retained for the following assay.
Assay for protein synthesis. Protein synthesis, directed by endogenous mRNA was estimated by the incorporation of 14C from labelled amino acids into hot trichloroacetic acid (TCA) precipitable material.
Cell-free extract (0.1 ml) was added to 0.1 ml of solution containing: ATP, 7-5 mM; GTP, I mM; and 14C-labelled amino acids in TAMKSH buffer, ~opCi/ml. This mixture, 'the complete system', was incubated at 37 "C for 40 min and then precipitated by the addition of TCA (final concentration 5 % , w/v), followed by heating at 90 "C for 20 min. Precipitates were collected, washed and dried on glass-fibre filters (Whatman GF/C), and radioactivity estimated by liquid scintillation using butyl-PBD-toluene (4 g/l) as scintillant. All experiments were done in duplicate and averaged.
R E S U L T S
Location of genes determining streptomycin resistance in strains 131 36, I I 164 and 2273. Following incubation at 43 "C, in the presence of 0.0075 pg rifampicin/ml, or 5 pg acriflavine/ml at least 3000 colonies from each strain were examined for loss of streptomycin resistance by replica plating. No loss of resistance was detected. This stability of resistance can be accounted for by either a chromosomal genetic locus or a stable plasmid. Further evidence for a chromosomal locus was obtained by studying the transduction kinetics from a mitomycin C lysate prepared from each strain. The transductants, selected on nutrient agar containing IOO pg streptomycin/ml, were counted after 48 h of incubation at 37 "C. Before plating, the recipient was incubated at 37 "C for 2 h to allow phenotypic expression. For each strain, the transduction frequency was stimulated more than 20-fold by low doses of u.v. irradiation (Fig. I) .
Although in one instance the transduction frequency of a plasmid gene is stimulated fivefold by U.V. light (Rubin & Rosenblum, 1971 ), a 20-fold or greater degree of stimulation is indicative of chromosomally located genes (Arber, I In a series of experiments transductants from lysates of strains 13 I 36, I I 164 and 609 str-r were selected on media containing I o ,ug streptomycin/ml. Transductants were replicated on to media containing 500 pg streptomycin/ml. About 50 colonies obtained from unirradiated lysates and 200 from lysates U.V. irradiated for 2 min were thus examined for each strain. No colony that grew at I o pg streptomycin/ml failed to grow at 500 pg/ml. This finding is consistent with the existence of a single genetic locus in strains 13136, 11164 and 2273. Strain 609 str-r is a one-step high-level mutant and therefore probably has a single locus for streptomycin resistance. This is confirmed by these results.
Failure to demonstrate streptomycin inactivation. No antibiotic inactivation was observed when streptomycin (50 pg/ml) was incubated with growing cultures of the resistant strains or with cell-free extracts.
Characteristics of cell-free system. Assay systems using extracts from all strains investigated exhibited properties expected of cell-free protein synthesizing systems. As an example an assay system using an extract from one of the strains is shown in Table I . The incorporation of radioactivity into protein was greatly reduced in the absence of ATP and GTP, or in the presence of ribonuclease, puromycin or chloramphenicol. The incorporation of radioactivity into protein was optimal at 20 mwmagnesium; this level is similar to that found for another staphylococcal cell-free system directed by endogenous mRNA (Mao, 1967) .
Efect of streptomycin on protein synthesis in the cell-free system. At a streptomycin concentration of I o pg/ml protein synthesis in extracts from two streptomycin-sensitive strains (8325 and 609) was more than 70% inhibited (Table 2) . Systems from both the laboratory mutant (609 str-r) and the clinical strains 13 t 36 and I I 16 showed less than 15 yo inhibition. At a lower concentration of streptomycin (0.5 pg/ml) inhibition of amino acid incorporation in extracts from the sensitive strains was approximately 50%, with no inhibition for 609 str-r, 13136, 11164, 2273 and 13137.
DISCUSSION
In three strains of Staphylococcus aureus obtained from clinical sources, the genes determining streptomycin resistance probably have a single chromosomal locus. Evidence for this conclusion is based on the stability of the resistance under various conditions and transduction kinetics. U.V. irradiation stimulated markedly the transduction frequency, and high-level resistance was always acquired by the recipient even when selected for low-level resistance. The genetic basis of streptomycin resistance in these strains closely resembled that of the laboratory mutant 609 str-r.
The mechanism of streptomycin resistance in these three, and in another clinical isolate (13137)~ seems to be identical to that of the laboratory strain 609 str-r. Cell-free extracts were prepared which incorporated amino acids into protein. Those derived from the resistant strains were unaffected by streptomycin at concentrations known to inhibit systems from sensitive organisms (Luzzatto, Apirion & Schlesinger, I 968) . Preparations from the streptomycin-sensitive strains (609 and 8325) were affected by as little as 0.3 pg streptomycin/ml. Possibly resistance to streptomycin is due to a modified component of protein synthesis other than the ribosome. However, such a mechanism is not known, and it is more likely that in both clinical and laboratory strains, resistance is ribosomal. Additionally, we have eliminated the possibilities that streptomycin resistance in these strains could be mediated Strep tomy cin resistance in s taphy lo coc ci 179 by enzymatic inactivation or streptomycin impermeability. Therefore, on the basis of genetic and biochemical evidence, the clinical strains resemble the laboratory mutants and the former may well have acquired Streptomycin resistance in vivo in a way comparable to strains in vitro.
Recent evidence suggests that the acquisition of multiple antibiotic resistance amongst enteric organisms is predominantly by R factors. In Staphylococcus aureus, genes determining resistance to a variety of antibiotics other than streptomycin are plasmid borne and transferable at medium-high frequencies between mixed cultures (e.g. Lacey, I 97 I) ; this may account for the high incidence of strains resistant to such antibiotics. However, clinical strains of Staphylococcus aureus may have acquired streptomycin resistance through a mutational step. Analysis of further staphylococci is needed before the significance of this type of resistance can be assessed.
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